Table 3.
Variable | Rectal group (n=450) | Intramuscular group (n=448) |
---|---|---|
Quinine doses (mg/kg) | 20.0 (18.1 to 22.0) | 12.8 (11.2 to 14.3) |
No of quinine administrations before switching to oral route | 3.4 (2.1 to 4.8) | 3.6 (2.3 to 5.0) |
No (%) with early treatment failure on day 3* | 26/417 (6) | 13/413 (3) |
Late clinical failure | 1 | 0 |
Late parasitological failure | 0 | 0 |
Fever clearance time (days) | 1.8 (0.5 to 3.1) | 1.7 (0.3 to 3.1) |
Time to oral intake (days) | 1.3 (0.2 to 2.3) | 1.3 (0.5 to 2.0) |
No (%) with fever recurrence on day 7† | 18/395 (5) | 37/375 (10) |
Absolute difference 3.0% (95% confidence interval 0.2% to 5.9%), P=0.05.
Intramuscular v rectal: absolute difference 5.3% (1.6% to 8.9%), P<0.005.